Assessment Of Pf-06291874 (Pf), A Glucagon Receptor Antagonist Administered As Monotherapy For Four Weeks In Patients With Type 2 Diabetes Mellitus (T2dm)Arthur Bergman,Beesan Tan,Veena Somayaji,Roberto A. Calle,David J. KazieradDIABETES（2016）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
